On 26 .04.2023 EFSA published the agenda for the Peer Review Experts’ Meetings in May 2023.
26th April 2023
EFSA expert meetings May 2023
26April
25th April 2023
EFSA Statement targeted assessment famoxadone
25April
EFSA published on 30.03.2023 a Statement on a targeted risk assessment for famoxadone.
24th April 2023
EFSA Statement on acibenzolar-S-methyl ED testing programme
24April
EFSA published a statement on the proposed testing strategy for assessing the ED properties of acibenzolar-S-methyl.
21st April 2023
EFSA reports on magnesium hydroxide as basic substance
21April
EFSA published a report (7902) on the outcome of the consultation with the Member States on the possible approval of magnesium hydroxide E 528 as a basic substance.
19th April 2023
EFSA opinion on imazalil MRLs
19April
EFSA published a reasoned opinion on the modification of MRLs for imazalil for cucumbers, courgettes and gherkins.
19th April 2023
EFSA opinion on pyridaben confirmatory MRL data
EFSA published a reasoned opinion on confirmatory data submitted in the context of the Article 12 review of all MRL data for pyridaben.
18th April 2023
EFSA opinion MRLs import tolerances fipronil
18April
EFSA published a reasoned opinion on the setting of import tolerances for fipronil.
19th March 2023
Agenda Expert meetings April 2023 published
19March
EFSA published on 17.03.2023 the agendas for the Peer Review Experts’ Meetings for April 2023.
3rd March 2023
Public consultation flurochloridone
03March
EFSA opened on 23.02.2023 a public consultation on the RAR for flurochloridone.
1st February 2023
EFSA conclusion ethephon
01February
On 31.01.2023 EFSA published its conclusion on the peer review of ethephon.
13th December 2022
EFSA reports on ED properties amisulbrom
13December
EFSA published on 09.12.2022 a Technical Report on the potential ED properties of amisulbrom.
13th December 2022
EFSA opinion MRLs spirotetramat
EFSA published on 12.12.2022 a reasoned opinion on the MRLs for spirotetramat in herbs and edible flowers.
8th November 2022
EFSA conclusions CPGV
08November
EFSA published on 07.11.2022 its conclusion on the peer review of Cydia pomonella granulovirus (CpGV).
27th October 2022
EFSA opinion on pyrethroid common metabolites
27October
EFSA published on 21.10.2022 a Scientific Opinion on the toxicity of pyrethroid common metabolites
26th October 2022
EFSa reports on BenchMark Dose Analysis
26October
On 25.10.2022 EFSA published two reports on Benchmark Dose (BMD) Analysis and announced an upcoming workshop on the topic.
25th October 2022
EFSA conclusion flutianil ED confirmatory data
25October
EFSA published on 17.110.2022 its conclusions on the confirmatory data on ED properties of flutianil.
3rd October 2022
EFSA conclusion rimsulfuron published
03October
On 29.09.2022 EFSA published its conclusions on the peer review of rimsulfuron.
3rd October 2022
Updated EFSA conclusion on benfluralin
EFSA published on 29.09.2022 (another) conclusion on benfluralin.
16th September 2022
EFSA reports on the use of Historical Control Data
16September
EFSA published on 02.09.2022 an external scientific report on the use of historical control data.
31st August 2022
EFSA conclusion abamectin
31August
EFSA published a new conclusion on the peer review of abamectin.